Kymera Therapeutics (KYMR) PT Raised to $155 at B.Riley
Get Alerts KYMR Hot Sheet
Price: $110.34 -2.67%
Rating Summary:
26 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 29
Rating Summary:
26 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 29
Join SI Premium – FREE
B.Riley analyst Kalpit Patel raised the price target on Kymera Therapeutics (NASDAQ: KYMR) to $155.00 (from $117.00) while maintaining a Buy rating.
You May Also Be Interested In
- Freedom Broker Upgrades Halliburton (HAL) to Hold
- Block Inc. (XYZ) PT Raised to $85 at BMO Capital
- Stellantis NV (STLA:IM) (STLA) PT Lowered to EUR5.50 at Kepler Cheuvreux
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share